Inpatient admitted patients are often at risk of various infections such as hospital acquired pneumonia (HAP) and to avoid the infection aseptic conditions are required to be maintained. The incidence of the HAP is around 0.5 to 2% of all hospital admissions, the infection further increases complexity of treatment, disease management cost, etc. Patients in which immune system is compromised are often at risk of the infection and in that scenario point of care infection control can play vital role for the prevention of the disease. It is reported that HAP affects 1 in every 1,000 discharges. Point of care infection control let’s limit or eliminate the infection lowering the risk of healthcare setting acquired infection. Infection could be from various sources but it is generally from the devices (equipments) used for operating the patient.
Point Of Care Infection Control Market: Drivers and Restraints
Increasing prevalence of the healthcare setting acquired infections such as HAP is expected to fuel the growth point of care infection control market. Increasing number of hospital or specialty clinic admission expected to further drive the growth of the point of care infection control market. Increased measures to limit the healthcare setting related infection further expected to propel the growth of point of care infection control market. Increasing number of surgical procedures, respiratory diseases requiring oxygen therapy, etc. requires higher aseptic conditions, which in turn expected to drive the growth of point of care infection control market across the world. Need for the healthcare setting to keep up with the standard protocol of operating devices and other equipment conditions further expected to drive the growth of point of care infection control market. Increasing expenditure by private players in the healthcare service providers sector further expected to drive the growth of point of care infection control market. Increasing awareness and understanding about the probable infections in inpatient setting further expected to drive the growth of point of care infection control market. Whereas, limited awareness in developing countries about the point of care infection control may hamper the potential growth of the market.
Download sample copy of this report:
https://www.futuremarketinsights.com/reports/sample/REP-GB-10625
Point Of Care Infection Control Market: Overview
The global point of care infection market expected to witness steady growth over the forecast period attributing to increasing use of point of care infection for sanitary conditions. By product type, germicidal wipes expected to be largest revenue generating segment in global point of care infection control market owing to higher adoption for sanitary condition maintenance. By end user, hospitals expected to be the most lucrative segment in global point of care infection control owing to higher number of healthcare settings across the world. Manufacturers in the point of care infection control market are trying to manufacturer product with greater antiseptic index and easier to use formulation.
Download Data Set @ https://www.futuremarketinsights.com/toc/rep-gb-10625
Point Of Care Infection Control Market: Regional Outlook
Global point of care infection control market is expected to be dominated by North America due to higher number of healthcare settings in the region. Latin America point of care infection control market is expected to witness steady growth over the forecast period due to increasing awareness about the possible hospital acquired infections. Europe is expected to be the second most lucrative point of care infection control market owing to higher product availability. Asia-Pacific is regarded as the emerging point of care infection control market due to improving healthcare infrastructure in the region. MEA is expected to be the least lucrative region in the global point of care infection control market.
Download Segment-wise Analysis@
https://www.futuremarketinsights.com/checkout/10625
Point Of Care Infection Control Market: Key Players
Key players operating in the global point of care infection control are: 3M, TheraDoc, Stanley Healthcare, BioVigil, SW Safety Solutions, HyGreen, Global Life Technologies Corp., Magnolia Medical Technologies and others.